Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v19-FR | Version v6-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2022-11-08 | 2022-10-04 |
| Drug Identification Number | 02465493 | 02465493 |
| Brand name | CUBICIN RF | CUBICIN RF |
| Common or Proper name | DAPTOMYCIN FOR INJECTION | DAPTOMYCIN FOR INJECTION |
| Company Name | CUBIST PHARMACEUTICALS LLC | CUBIST PHARMACEUTICALS LLC |
| Ingredients | DAPTOMYCIN | DAPTOMYCIN |
| Strength(s) | 500MG | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 mL Vial | 10 mL Vial |
| ATC code | J01XX | J01XX |
| ATC description | OTHER ANTIBACTERIALS | OTHER ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-10-26 | 2022-10-24 |
| Actual start date | 2022-10-25 | |
| Estimated end date | 2022-11-09 | 2022-10-31 |
| Actual end date | 2022-11-07 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Sunovion Pharmaceuticals Canada Inc. regrets to advise of an anticipated shortage of CUBICIN RF®. Current inventories are anticipated to be depleted approximately October 26, 2022. We are working with buyers to manage order allotment in an effort to minimize the impact as much as possible. The next shipment of inventory is expected to be available by late October 2022. We will provide updates as new information becomes available. Customer Service / service à la clientèle : 1-888-363-0205 Email / courriel : csrsunovion@accuristix.com | Sunovion Pharmaceuticals Canada Inc. regrets to advise of an anticipated shortage of CUBICIN RF®. Current inventories are anticipated to be depleted approximately October 24, 2022. We are working with buyers to manage order allotment in an effort to minimize the impact as much as possible. The next shipment of inventory is expected to be available by late October 2022. We will provide updates as new information becomes available. Customer Service / service à la clientèle : 1-888-363-0205 Email / courriel : csrsunovion@accuristix.com |
| Health Canada comments |